Colistin, rifampicin, and meropenem administered as single agents in a model of pneumonia caused by a carbapenem-resistant Acinetobacter baumannii

被引：4
|
作者：
Cassisa, Viviane [1 ,2 ]
Joly-Guillou, Marie-Laure [1 ,2 ]
Pailhories, Helene [1 ,2 ]
Coron, Noemie [2 ]
Eveillard, Matthieu [1 ,2 ]
机构：
[1] Grp Etude Interact Hotes Pathogenes, GEIHP, UPRES EA 3142, Corsica, France
[2] CHU Angers, Lab Bacteriol Hyg, F-49000 Angers, France
来源：
JOURNAL OF INFECTION | 2014年 / 69卷 / 05期
关键词：
EFFICACY; IMIPENEM;
D O I：
10.1016/j.jinf.2014.07.003
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：516 / +
页数：2
相关论文
共 50 条
  • [31] The Rise of Carbapenem-Resistant Acinetobacter baumannii
    Evans, Benjamin A.
    Hamouda, Ahmed
    Amyes, Sebastian G. B.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (02) : 223 - 238
  • [32] Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model
    Liu, Xiaofen
    Zhao, Miao
    Chen, Yuancheng
    Bian, Xingchen
    Li, Yunfei
    Shi, Jun
    Zhang, Jing
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (05) : 559 - 563
  • [33] CLINICAL EFFICACY OF SITAFLOXACIN-COLISTIN-MEROPENEM AND COLISTIN-MEROPENEM AMONG CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII HOSPITAL-ACQUIRED PNEUMONIA/VENTILATOR-ASSOCIATED PNEUMONIA PATIENTS: A SINGLE-BLINDED, RANDOMIZED CONTROLLED TRIAL
    Wantanatavatod, M.
    Wongkulab, P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S57 - S58
  • [34] Carbapenem-resistant Acinetobacter baumannii septicemia and meningitis in a neonate treated with colistin and netilmycin
    Lumbiganon, Pagakrong
    Kosalaraksa, Pope
    Teeratakulpisarn, Jamaree
    Kitkhuandee, Amnat
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2008, 3 (04) : 283 - 285
  • [35] Evaluation of the Efficacy of Colistin/Sulbactam Combination on Carbapenem-Resistant Acinetobacter baumannii Strains
    Cetinkol, Yeliz
    Telli, Murat
    Altuncekic Yildirim, Arzu
    Calgin, Mustafa Kerem
    MIKROBIYOLOJI BULTENI, 2016, 50 (03): : 460 - 465
  • [36] Treatment outcome of pneumonia due to carbapenem-resistant Acinetobacter baumannii complex
    Choi, W. S.
    Lee, S.
    Moon, C.
    Park, D. W.
    Song, J. Y.
    Cheong, H. J.
    Kim, J.
    Kim, J. Y.
    Park, M. N.
    Kim, Y. R.
    Lee, H. -J.
    Kim, B.
    Pai, H.
    Jo, Y. M.
    Kim, J. H.
    Sohn, J. W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S156 - S157
  • [37] Colistin monotherapy versus colistin/rifampicin combination therapy in pneumonia caused by colistin-resistant Acinetobacter baumannii: A randomised controlled trial
    Park, Hye Jung
    Cho, Jae Hwa
    Kim, Hyung Jung
    Han, Sang Hoon
    Jeong, Seok Hoon
    Byun, Min Kwang
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 17 : 66 - 71
  • [38] Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii
    Park, Suyeon
    Jin, Yanhong
    Ko, Kwan Soo
    MICROBIOLOGY SPECTRUM, 2025, 13 (02)
  • [39] In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii
    Yong Guk Ju
    Hak Joon Lee
    Hong Soon Yim
    Min-Goo Lee
    Jang Wook Sohn
    Young Kyung Yoon
    Scientific Reports, 12
  • [40] In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii
    Ju, Yong Guk
    Lee, Hak Joon
    Yim, Hong Soon
    Lee, Min-Goo
    Sohn, Jang Wook
    Yoon, Young Kyung
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345